Xencor | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
AbbVie USD 5.52B 1.73B 2024-12
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amgen USD 8.81B 3.16B 2025-03
Arrowhead Research USD 185.71M 133.92M 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Biogen USD 2.6B 223.3M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Cytokinetics USD 938.22M 843.36M 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
J&J USD 38.47B 32.35B 2025-03
MacroGenics USD 182.84M 3.22M 2024-12
Merck USD 8.63B 4.61B 2025-03
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.43B 387M 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Xencor USD 39.67M 1.2M 2025-03



Xencor Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.